Nicholas Petracca - Profile and Investment Details

Investor Profile

Nicholas Petracca is a Venture Capital, Investment Bank, Corporate Venture Capital, Private Equity Firm based in Manhasset, New York, United States with a diverse investment portfolio that includes companies such as GlobeImmune, Orchestra BioMed, Armada Water Assets, Motus GI, Helocyte, Outstanding Foods, Hydrofarm, Adgero Biopharmaceuticals, Deem, BackBeat Medical, Organovo Holdings, Kintara Therapeutics, Caliber Therapeutics, PROLOR Biotech, DarioHealth, InVivo Therapeutics, Corbus Pharmaceuticals, MATINAS BIOPHARMA, Aerami Therapeutics, . Over time, Nicholas Petracca has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Nicholas Petracca is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Strategic Consulting Tech, Consumer Goods, Investment Management, Android, Strategic Partnerships, Portfolio Management, Wholesale, Cloud Computing, Diabetes, Finance, Software, Manufacturing, Biotechnology, Market Research, Productivity Software, Nutrition, Food and Beverage, Groceries, Agriculture, Consulting, Regulatory Compliance, Medical, B2B, Therapeutics, Financial Advisory, Risk Management may find it worthwhile to explore potential connections with Nicholas Petracca, as their portfolio suggests a familiarity and interest in this area.

Understanding Nicholas Petracca’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.